Will Morton

Molecular Imaging
What impact will flurpiridaz F-18 have on heart care?
Seventeen years was all it took for flurpiridaz F-18 to reach the market, with the first patient injected with the PET imaging agent in November, 2007.
October 4, 2024
Maddahi
Digital X-Ray
CDC considers chest x-ray AI for TB screening program
The U.S. CDC is considering the use of AI to back up its tuberculosis screening program for immigrants and refugees.
October 3, 2024
XRAI (left) and GradCAM (right) heatmaps for true positive images. The original radiographs are on the left, the Grad-CAM activations and heatmaps are in the middle, and the XRAI activations and overlays are on the right. For the XRAI overlays, only regions reaching the 70th percentile of activation strength are shown. Images available under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of PLOS Digital Health.
AI
GPT-4V flops on RSNA ‘Case of the Day’ questions
U.S. National Institutes of Health investigators have found that GPT-4 Vision in its current form is not able to reliably interpret radiologic images.
October 1, 2024
Chatgpt 4
Molecular Imaging
PET identifies risk of metastases in patients with HNSCC
PET imaging with F-18 fluoromisonidazole can determine whether cancer may spread in patients undergoing chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC).
October 1, 2024
Headandneck2
Radiation Oncology/Therapy
ASTRO: Black patients voice distrust in medical research
Spiritual beliefs and a distrust of clinical research may partly explain why Black patients choose not to participate in cancer trials.
September 30, 2024
Black Patient
Radiation Oncology/Therapy
ASTRO: IMRT and proton therapy equally effective for prostate cancer
Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer.
September 30, 2024
Prostate Imaging
Nuclear Medicine
FDA approves flurpiridaz F-18 PET tracer for imaging heart disease
GE HealthCare
The U.S. Food and Drug Administration (FDA) approved the radiotracer flurpiridaz F-18 September 27 for PET imaging of coronary artery disease.
September 27, 2024
Fda
Interventional
GAE could be cost-effective for knee osteoarthritis
Genicular artery embolization (GAE) is likely a cost-effective treatment for symptomatic knee osteoarthritis.
September 26, 2024
Knee
Digital X-Ray
Vitamin D benefits during pregnancy extend to 7-year-olds
DEXA scans indicate that vitamin D supplementation during pregnancy results in greater bone mineral density in children up to age 7.
September 26, 2024
Pregnancy
Molecular Imaging
Nuclear cardiology could face cuts in 2025
Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert.
September 25, 2024
Larry Phillips, MD
Previous Page
Page 17 of 50
Next Page
Top Stories
2026 02 12 Chest Ac2 Thumbnail
Digital X-Ray
Chest x-rays reveal atherosclerosis in patients undergoing amputations
Lower limb amputation is an increasingly common major complication of advanced peripheral arterial disease and diabetes mellitus.
Cardiac Mri Adobe Samunella
MRI
3D MRI technique helps plan treatment for pediatric heart conditions
Images of a 39-year-old who underwent screening mammography. Right craniocaudal (left) and mediolateral oblique (middle) views from preoperative mammography show suspicious grouped fine pleomorphic calcifications (arrows). After biopsy showed ductal carcinoma of situ (DCIS), patient underwent breast-conserving surgery, yielding final diagnosis of ductal carcinoma in situ (intermediate grade, hormone receptor positive). (Right) Screenshot of an output of a commercial AI tool applied to preoperative mammography. AI detected right breast lesion with score of 95% on both views (concentric colored circles). Present study’s reviewing radiologist deemed AI marking to correspond with site of DCIS.
Womens Imaging
Could AI scoring help with managing DCIS?
Axial contrast-enhanced CT scan in a 28-year-old premenopausal woman shows an incidentally detected solid-appearing left ovarian lesion (solid arrow) anterior to the uterus (U), associated with trace ascites in the right adnexa and cul de sac (dashed arrows). At pathologic analysis, this was shown to be ovarian dysgerminoma. Two readers misdiagnosed this lesion, one as a leiomyoma and one as an ovarian fibroma.
CT
Clinicians, beware: CT diagnostic accuracy varies by adnexal lesion type
Erin Stephens
Practice Management
Radiology coding update for 2026
More in Home
Use precontrast, low attenuation CT to better identify liver cancer
By Kate Madden Yee
Precontrast low attenuation on CT shows up as a region darker than surrounding tissues because fewer x-rays are being blocked.
November 25, 2025
2025 11 25 Radiology Park Figure2 Thumbnail
MRgFUS opens blood-brain barrier for chemotherapy
By Amerigo Allegretto
MRgFUS successfully opened the blood-brain barrier in cancer patients for chemotherapy to be delivered to target regions.
November 25, 2025
Graeme Woodworth, MD, works at his station. Woodworth led the study on MRgFUS for opening the blood-brain barrier to deliver chemotherapy for glioblastoma patients.
Does the shape of our buttocks signal diabetes?
By Will Morton
In participants with type 2 diabetes, MRI showed that men had muscle shrinkage, while women showed enlarged muscles.
November 25, 2025
2025 11 21 Buttock Mri Image Thumbnail
Imaging biomarker emerges as chronic stress measure
By Liz Carey
Adrenal volume acts like a "biological barometer" of chronic stress, according to Johns Hopkins researchers.
November 25, 2025
2025 11 21 2d 3d Segmentation Chestct Thumbnail
New SPECT/CT tracer visualizes distribution of ALS drug
By Will Morton
Tofersen has been approved for treating amyotrophic lateral sclerosis (ALS), but its regional brain uptake is not fully understood.
November 25, 2025
SPECT imaging of Tc-99m MAG3-tofersen in healthy human volunteers. (A) Maximum-intensity-projection images showing distribution of Tc-99m MAG3-tofersen in humans (n = 3) one, four, and 24 hours after intrathecal injection. Time–activity curves derived from SPECT data measuring activity in ROIs in CNS (lumbar, thoracic, and cervical spine ROIs include both cord and proximal CSF) (B), kidneys and liver (C), and brain atlas (D).
Your network doesn't matter anymore
By Rishi Nayyar
Agentic AI is rewriting the rules, according to PocketHealth Co-Founder and CEO Rishi Nayyar.
November 25, 2025
Nayyar Rishi Thumbnail
How are imaging modalities portrayed in movies?
By Amerigo Allegretto
Feature-length films often portray medical imaging in a negative light, including MRI, ultrasound, and mammography.
November 24, 2025
Movie Theater Adobe Mr Music
Higher muscle mass, decreased belly fat equals a healthy brain
By Kate Madden Yee
The research suggests that "improving muscle mass and reducing visceral fat may improve brain aging," investigators wrote.
November 24, 2025
2025 11 21 Body Fat Image Thumbnail
Art and radiology: Seeing beauty and value in images
By Philip Ward
In a Q&A interview, Harun Yildiz, MD, discusses the intersection of medical imaging and art.
November 24, 2025
2025 11 20 Thumbnail
The paradox of AI in lung nodules
By Chris Wood
In this column, RevealDx CEO Chris Wood describes a pathway to reducing lung cancer mortality that isn't being fully utilized in the U.S.
November 24, 2025
Chris Wood, CEO of RevealDx
AI detects meningiomas on skull x-rays
By Will Morton
X-rays can reveal characteristic features of meningiomas, such as thickening of the skull bone.
November 21, 2025
2025 11 21 Ai Meningiomas Thumbnail
House members reintroduce Find It Early Act
By Amerigo Allegretto
Members of the U.S. House of Representatives have reintroduced the Find It Early Act to remove barriers to breast imaging.
November 21, 2025
Capitol Hill Government
Previous Page
Page 17 of 202
Next Page